C
CardioLogs
Health Tech & Medtech · Paris, France · Founded 2014
Democratizes expert cardiac care globally, by empowering all actors in the care chain with AI MoreLess
Cardiologs is a pioneering company in the field of medical-grade artificial intelligence (AI) focused on transforming the way cardiovascular diseases are diagnosed and managed. The company operates in the digital health market, providing an AI-powered platform that offers accurate and automated analysis of electrocardiograms (ECGs). Cardiologs serves healthcare professionals, including physicians and clinicians, by providing them with intelligent tools to enhance their diagnostic capabilities. The platform is clinically validated and can detect more than 20 types of arrhythmia events, significantly improving the specificity and sensitivity of diagnoses. Cardiologs generates revenue through a subscription-based business model, offering its platform to healthcare institutions and professionals on a recurring basis. By streamlining operational workflows and providing clinical accuracy, Cardiologs aims to empower clinicians and improve patient care globally.
Keywords: AI-powered, ECG analysis, arrhythmia detection, digital health, medical-grade AI, healthcare professionals, clinical accuracy, automated analysis, subscription model, patient care.
Company overview
CardioLogs company information
The essential company record, classifications and operating signals in one place.
- Status
- Closed
- Founded
- 2014
- Headquarters
- Paris, France
- Employees
- 64
- Open positions
- 6
- Dealroom signal
- 0.0
Valuation & funding
CardioLogs funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITION✓Exit | Nov 2021 | $0 | — | Philips | — |
| SERIES A✓Equity / VC | Jan 2020 | $15M | $60M | Kurma Partners · ISAI Gestion · Partech · Eurazeo | ↗ |
| SERIES A✓Equity / VC | Oct 2017 | $6.4M | $26M | Partech · Eurazeo · Kurma Partners · Wilco | ↗ |
| SEED✓Equity / VC | Dec 2015 | $1.1M | $4.4M | Bpifrance | — |
| ANGELEquity / VC | May 2015 | $132K | $528K | Undisclosed | — |
| ANGEL✓Equity / VC | Jul 2014 | Undisclosed | — | ||
| ANGEL✓Equity / VC | Jul 2014 | Undisclosed | — | ||
| ANGEL✓Equity / VC | Mar 2014 | Undisclosed | — |
Financials
Revenue, earnings and profit over time
Reported history and available estimates. Estimated years are marked “E”; sparse fields are left blank rather than inferred.
| Year | Revenue | Growth | Profit | Margin |
|---|---|---|---|---|
| 2026 | $3.4M | 0% | −$8.2M | -243.2% |
| 2025 | $3.4M | 0% | −$8.2M | -243.2% |
| 2024 | $3.4M | 0% | −$8.2M | -243.2% |
| 2023 | $3.4M | 0% | ||
| 2022 | $3.4M | 0% | ||
| 2021 | $3.4M | +183.1% | ||
| 2020 | $1.2M | — |
Growth signals
CardioLogs website traffic
Latest recorded traffic for CardioLogs is 15K monthly website visits, up 80.7% over the last three months. CardioLogs's team declined 22% over the past year.
Hiring
Open positions at CardioLogs
Current openings linked to this company in Dealroom.
Comparisons
CardioLogs compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
CardioLogs's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where CardioLogs has talent and traffic
team presence
In the news
Latest news about CardioLogs
Recent press, funding announcements, and product moves mentioning CardioLogs — open to read from the original sources.
Market sentiment
What the market is saying about CardioLogs
An AI-synthesized read of the highest-engagement posts about CardioLogs on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See CardioLogs’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.